Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ARCpoint Inc V.RSY


Primary Symbol: V.ARC Alternate Symbol(s):  ARCPF

ARCpoint Inc. is a health care company. The Company provides a United States-based franchise system offering drug testing, alcohol screening, deoxyribonucleic acid (DNA) and clinical lab testing, corporate wellness programs and employment and background screening and other services. Its segments include ARCpoint Franchise, AFG Services, and Other. The ARCpoint Franchise segment includes franchise labs. The AFG Services segment consists primarily of clinical testing and software services that support its franchise systems. This segment also includes diagnostic testing kits sold to franchisees as well as other direct business to business customers. The Other segment consists of corporately held ARCpoint Lab franchises. The Company sells franchises to individuals throughout the United States and provides support in the form of marketing, technology, and training to new franchisees. It develops corporate-owned labs committed to providing solutions for customers, businesses, and physicians.


TSXV:ARC - Post by User

Comment by PlanetURFon Sep 17, 2018 2:24pm
154 Views
Post# 28633974

RE:RE:News: RSI Int'l to sell RoomKeyPMS business for $4.6M (U.S.)

RE:RE:News: RSI Int'l to sell RoomKeyPMS business for $4.6M (U.S.)This business is valuable because they can probably cut $400k in duplicate costs. And 75% of new revenue will flow to the bottom line with current revenues quite stable even in a very competitive environment. Customer acquisition costs are quite low as well. Some SaaS companies have 30-40% sales costs with low growth. 

At 1x revenue they are getting a bargain here imo. Take out a competitor and every 1$ million of revenue is probably $750k of EBIT down to the bottom line. 

They should have done a merger instead of straight up selling it. 5-10 years from now they will regret this. If they do not payout the proceeds it should trade at a sizable discount.
<< Previous
Bullboard Posts
Next >>